EP0576914A3 - 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires. - Google Patents

14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires. Download PDF

Info

Publication number
EP0576914A3
EP0576914A3 EP93109611A EP93109611A EP0576914A3 EP 0576914 A3 EP0576914 A3 EP 0576914A3 EP 93109611 A EP93109611 A EP 93109611A EP 93109611 A EP93109611 A EP 93109611A EP 0576914 A3 EP0576914 A3 EP 0576914A3
Authority
EP
European Patent Office
Prior art keywords
thioderives
cardenolied
deoxy
beta
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP93109611A
Other languages
German (de)
English (en)
Other versions
EP0576914A2 (fr
Inventor
Mauro Gobbini
Luigi Bernardi
Mara Ferrandi
Piero Melloni
Luisa Quadri
Roberto Villa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of EP0576914A2 publication Critical patent/EP0576914A2/fr
Publication of EP0576914A3 publication Critical patent/EP0576914A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EP93109611A 1992-07-01 1993-06-16 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires. Ceased EP0576914A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221538A DE4221538C1 (de) 1992-07-01 1992-07-01 14-Desoxy-14alpha-cardenolid-3beta-thioderivate
DE4221538 1992-07-01

Publications (2)

Publication Number Publication Date
EP0576914A2 EP0576914A2 (fr) 1994-01-05
EP0576914A3 true EP0576914A3 (fr) 1995-04-19

Family

ID=6462209

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93109611A Ceased EP0576914A3 (fr) 1992-07-01 1993-06-16 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires.

Country Status (4)

Country Link
US (1) US5489582A (fr)
EP (1) EP0576914A3 (fr)
JP (1) JPH0733795A (fr)
DE (1) DE4221538C1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1282286B1 (it) * 1995-05-11 1998-03-16 Sigma Tau Ind Farmaceuti Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3268520A (en) * 1963-01-23 1966-08-23 Bayer Ag Steroid guanylhydrazones and production thereof
FR1491081A (fr) * 1965-09-01 1967-08-04 Hoechst Ag Lactones non saturées de la série des stéroïdes et leur préparation
FR1555396A (fr) * 1967-03-10 1969-01-24
FR2100872A1 (fr) * 1970-07-07 1972-03-24 Hoechst Ag

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1038294A (fr) * 1975-04-14 1978-09-12 American Home Products Corporation Methode et composes pour abaisser la pression intraoculaire
DE2517293C2 (de) * 1975-04-18 1984-02-16 Knoll Ag, 6700 Ludwigshafen Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung
FR2310766A1 (fr) * 1975-05-16 1976-12-10 Nativelle Sa Ets Derives de cardenolides, procede de preparation et application a titre de medicament
DE2833472A1 (de) * 1978-07-29 1980-03-06 Beiersdorf Ag Digitoxigenin-monodigitoxosid-derivate und verfahren zu ihrer herstellung
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3268520A (en) * 1963-01-23 1966-08-23 Bayer Ag Steroid guanylhydrazones and production thereof
FR1491081A (fr) * 1965-09-01 1967-08-04 Hoechst Ag Lactones non saturées de la série des stéroïdes et leur préparation
FR1555396A (fr) * 1967-03-10 1969-01-24
FR2100872A1 (fr) * 1970-07-07 1972-03-24 Hoechst Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAIDOO B K ET AL: "Cardiotonic steroids. I. Importance of 14.beta.-hydroxy group in digitoxigenin", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 63, no. 9, September 1974 (1974-09-01), WASHINGTON US, pages 1391 - 1394, XP002394977, DOI: doi:10.1002/jps.2600630912 *

Also Published As

Publication number Publication date
US5489582A (en) 1996-02-06
DE4221538C1 (de) 1994-03-31
EP0576914A2 (fr) 1994-01-05
JPH0733795A (ja) 1995-02-03

Similar Documents

Publication Publication Date Title
FR2578421B1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
MA26586A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant
OA07124A (fr) Dipeptides substitués, procédés pour leur préparation et compositions pharmaceutiques les contenant et leur utilisation pour l'inhibition de l'encéphalinase.
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
DZ2752A1 (fr) Composés et compositions pharmaceutiques pour le traitement du paludisme.
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
FR2712495B1 (fr) Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant.
FR2718354B1 (fr) Application des composés antiglucocorticoïde pour la préparation de médicaments destinés à la prévention ou au traitement des manifestations liées au syndrome de sevrage des narcotiques et les compositions les renfermant.
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
EP0719552A3 (fr) Compositions pharmaceutique contenant un dérivé quinoné ou hydroquinone pour le traitement des dermatites
EP0576914A3 (fr) 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires.
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2691064B3 (fr) Nouveau medicament pour le traitement de l'arythmie.
EP0576913A3 (fr) Digitoxigenin et dihydrodigitoxigenin 3-béta-dérivés et compositions pharmaceutiques les contenant, pour le traitement des troubles cardiovasculaires.
FR2684301B1 (fr) Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
FR2732219B1 (fr) Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes
FR2646352B3 (fr) Nouvelles compositions pharmaceutiques pour le traitement de la constipation et leur procede d'obtention
BE896891A (fr) Compositions lipolytiques et medicaments pour le traitement de l'obesite.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17P Request for examination filed

Effective date: 19950626

17Q First examination report despatched

Effective date: 19951012

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

K1C1 Correction of patent application (title page) published

Effective date: 19940105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19970804